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Objectives:
Introduction:
Technological innovation opens the possibility for scientific discovery, especially in biology and medicine, which
allows the development of different perspectives that can bring a new understanding regarding different pathologies.
Technologies such as the Next-Generation Sequencing (NGS) allow us not only to decode the human genome but also to
describe and identify gene polymorphisms that lead to the development of diseases, as it happens with monogenic obesity.
Methodology:
From 36 obese individuals (BMI > 30 kg/m2) from Portugal, all patients from Curry Cabral Hospital, DNA was
extracted from mouth epithelial cells (ExtractMe®, from BLIRT SA®) and then analysed in NGS equipment (Illumina
NexTSeq550 with the kit TruSight One® from Illumina, Inc.) using a 24 gene panel associated with monogenic obesity:
Gene Panel:
ADRB1 ADRB2 ADRB3 BDNF FTO
IGF2R LEP LEPR LRP2 MC3R
MC4R NEGR1 NPY NPY1R NPY2R
NTRK2 PCSK1 POMC SH2B1 SIM1
SORCS1 UCP1 UCP2 UCP3
Results:
A total of 183 snv variants and 3 indels were identified, where 141 were heterozygous: 
Figure 1 - Number of samples with variants in each gene. Figure 2 – Number of variants in each sample.
2 nondescribed missense mutations were identified
LRP2 12385A>G gene
SORCS1 2491A>C gene
2 samples showed possibly damaging 
mutations, according to polyphen
classification, for the POMC gene.
Conclusion:
NGS shows potential not only as a diagnostic tool in pathologies such as obesity, but also as a research tool by
identifying undescribed and unclassified gene mutations. These methodologies can open new possibilities for the
medical field not only in diagnosis but also in preventive medicine and new approaches in personalized treatments.
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